Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Danaher (DHR) , which belongs to the Zacks Diversified Operations industry.When looking at the last two reports, this industrial and medical device maker has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 10.19%, on average, in the last two quarters.For the last reported quarter, Danaher came out with earnings o ...

Danaher Corporation (DHR) is scheduled to release first-quarter 2024 results on Apr 23, before market open.The company’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 6.8%. In the last reported quarter, its earnings of $2.09 per share beat the consensus estimate of $1.90 by 10%.Let’s see how things have shaped up for Danaher this earnings season.Key Factors and Estimates for Q1Improving supply chains and strong price realization are expecte ...

Wall Street analysts forecast that Danaher (DHR) will report quarterly earnings of $1.72 per share in its upcoming release, pointing to a year-over-year decline of 27.1%. It is anticipated that revenues will amount to $5.64 billion, exhibiting a decline of 21.3% compared to the year-ago quarter.The consensus EPS estimate for the quarter has been revised 0.5% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimat ...

公司业绩 - 公司市值为180.7亿美元，过去六个月股价上涨16.5%，行业增长为5.4%[2] - 公司目前持有Zacks Rank 2 (Buy)评级[2] - 公司受益于生命科学领域的实力，受到学术和生命科学研究市场的强劲需求推动[3] 产品创新 - 公司新产品如IDBS的Polar Insight和Molecular Devices的CellXpress.ai受到积极回应，有助于加快药物发现过程和更快地推出新疗法[4] 收购业务 - 公司专注于收购业务以获得新客户、地区和产品线，2023年12月收购了全球蛋白消耗品供应商Abcam plc，扩大了公司的生命科学部门[5] 公司战略 - 公司通过Danaher Business System (DBS)倡议，专注于产品创新、卓越产品质量、高效的员工建设和股东价值增值，促进公司增长[6] 股东回报 - 公司致力于通过股息支付回报股东，2023年支付的股息为8.21亿美元，同比增长0.4%，2024年2月季度股息率提高了12.5%至每股27美分[7]

Danaher (DHR) ended the recent trading session at $244.28, demonstrating a +0.98% swing from the preceding day's closing price. This move lagged the S&P 500's daily gain of 1.11%. Meanwhile, the Dow experienced a rise of 0.8%, and the technology-dominated Nasdaq saw an increase of 1.24%.The industrial and medical device maker's shares have seen a decrease of 4.81% over the last month, not keeping up with the Conglomerates sector's loss of 4.23% and the S&P 500's gain of 0.48%.The investment community will b ...

Danaher (DHR) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this industrial and medical device maker have returned -3.4% over the past month versus the Zacks S&P 500 composite's +1.6% change. The Zacks Diversified Operations industry, to which Danaher belongs, has lost 3.3% over this period. Now the key question is: Where could the stock be headed in th ...

The latest trading session saw Danaher (DHR) ending at $245.94, denoting a -0.75% adjustment from its last day's close. The stock trailed the S&P 500, which registered a daily loss of 0.72%. At the same time, the Dow lost 1%, and the tech-heavy Nasdaq lost 0.95%.The industrial and medical device maker's shares have seen a decrease of 3.28% over the last month, not keeping up with the Conglomerates sector's gain of 2.78% and the S&P 500's gain of 2.16%.The upcoming earnings release of Danaher will be of grea ...

WASHINGTON, March 21, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2024 on Tuesday, April 23, 2024 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading ...

Danaher (DHR) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this industrial and medical device maker have returned +0.4% over the past month versus the Zacks S&P 500 composite's +3.6% change. The Zacks Diversified Operations industry, to which Danaher belongs, has gained 6.5% over this period. Now the key question is: Where could the stock be headed in ...

Danaher (DHR) closed the most recent trading day at $251.47, moving +0.83% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.63% for the day. Meanwhile, the Dow experienced a rise of 0.2%, and the technology-dominated Nasdaq saw an increase of 0.82%.The industrial and medical device maker's shares have seen a decrease of 0.24% over the last month, not keeping up with the Conglomerates sector's gain of 5.08% and the S&P 500's gain of 1.76%.Analysts and investors ...